SCHEMBL25020089

SCHEMBL25020089

CCCc1c(CC)nc(OC[C@H](C)C[C@@H](F)CC)nc1N(CCC)C[C@@H](C)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21846275 0.86 — —
SCHEMBL21846280 0.85 — —
SCHEMBL21846435 0.82 — —
SCHEMBL25020009 0.78 — —
SCHEMBL25021051 0.76 KDM4E (0.30) —
SCHEMBL21895625 0.75 — —
SCHEMBL21846187 0.75 — —
SCHEMBL21846281 0.75 — —
SCHEMBL21895575 0.74 — —
SCHEMBL21895589 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
Send feedback